|
Volumn 140, Issue 3, 2005, Pages 505-506
|
Chemoreduction in the management of retinoblastoma
a,c a b |
Author keywords
[No Author keywords available]
|
Indexed keywords
CARBOPLATIN;
CYCLOSPORIN;
ETOPOSIDE;
VINCRISTINE;
BEAM THERAPY;
CRYOTHERAPY;
DISEASE ASSOCIATION;
EDITORIAL;
ENUCLEATION;
FOLLOW UP;
HUMAN;
IN VITRO STUDY;
LASER COAGULATION;
LYMPHATIC LEUKEMIA;
PHYSICIAN;
PRIORITY JOURNAL;
RECURRENT DISEASE;
RETINOBLASTOMA;
RISK FACTOR;
VISION;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BRACHYTHERAPY;
CARBOPLATIN;
COMBINED MODALITY THERAPY;
CRYOTHERAPY;
DISEASE-FREE SURVIVAL;
EYE ENUCLEATION;
HUMANS;
INFANT;
INFANT, NEWBORN;
LASER COAGULATION;
RETINAL NEOPLASMS;
RETINOBLASTOMA;
VINCRISTINE;
|
EID: 24044432008
PISSN: 00029394
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ajo.2005.04.047 Document Type: Editorial |
Times cited : (33)
|
References (4)
|